Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1955 Jun;14(2):195–197. doi: 10.1136/ard.14.2.195

Serum Antiplasmin and Plasmin in Rheumatoid Arthritis

D P Page Thomas 1, J T M Dingle 1
PMCID: PMC1006800  PMID: 14388598

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BIDWELL E. Fibrinolysins of human plasma; a comparison of fibrinolytic plasma from normal subjects and from cadaver blood with plasmin prepared by activation with chloroform. Biochem J. 1953 Oct;55(3):497–506. doi: 10.1042/bj0550497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Coke H. Serum Anti-Tryptase in Chronic Rheumatic Disease. Ann Rheum Dis. 1949 Jun;8(2):135–138. doi: 10.1136/ard.8.2.135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. FEARNLEY G. R., REVILL R., TWEED J. M. Observations on the inactivation of fibrinolytic activity in shed blood. Clin Sci. 1952 Aug;11(3):309–314. [PubMed] [Google Scholar]
  4. Guest M. M., Daly B. M., Ware A. G., Seegers W. H. A STUDY OF THE ANTIFIBRINOLYSIN ACTIVITY IN HUMAN PLASMAS DURING PATHOLOGICAL STATES. J Clin Invest. 1948 Nov;27(6):793–794. doi: 10.1172/JCI102030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. HAMMARSTEN G., JONSSON E., HANSEN J. Investigation of the enzymatic activity in rheumatoid arthritis. I. The activity of plasmin in plasma from patients with rheumatoid arthritis. Acta Med Scand. 1954;147(5-6):359–362. doi: 10.1111/j.0954-6820.1954.tb11392.x. [DOI] [PubMed] [Google Scholar]
  6. Holmes W. F., Keefer C. S., Myers W. K. ANTI-TRYPTIC ACTIVITY OF SYNOVIAL FLUID IN PATIENTS WITH VARIOUS TYPES OF ARTHRITIS. J Clin Invest. 1935 Jan;14(1):124–130. doi: 10.1172/JCI100647. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. JENSEN H., CHAMOVITZ D. L., VOLKRINGER E., GRAY E., GOSNEY J. E., KOCHOLATY W. Antifibrinolytic activity in plasma after exposure to cold and after chymotrypsin administration. Blood. 1953 Apr;8(4):324–328. [PubMed] [Google Scholar]
  8. MULLERTZ S. The action of plasmin on fibrin and fibrinogen in blood. Acta Physiol Scand. 1953 Mar 31;28(1):29–40. doi: 10.1111/j.1748-1716.1953.tb00957.x. [DOI] [PubMed] [Google Scholar]
  9. RAGAN C., GROKOEST A. W., BOOTS R. H. Effect of adrenocorticotrophic hormone on rheumatoid arthritis. Am J Med. 1949 Dec;7(6):741–750. doi: 10.1016/0002-9343(49)90412-x. [DOI] [PubMed] [Google Scholar]
  10. REMMERT L. F., COHEN P. P. Partial purification and properties of a proteolytic enzyme of human serum. J Biol Chem. 1949 Nov;181(1):431–448. [PubMed] [Google Scholar]
  11. SHULMAN N. R. Studies on the inhibition of proteolytic enzymes by serum. III. Physiological aspects of variations in proteolytic inhibition. The concurrence of changes in fibrinogen concentration with changes in trypsin inhibition. J Exp Med. 1952 Jun;95(6):605–618. doi: 10.1084/jem.95.6.605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. TRUELOVE S. C. The lability of human fibrinolysin. Clin Sci. 1953 Feb;12(1):75–79. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES